Breaking News Instant updates and real-time market news.

MRTX

Mirati Therapeutics

$10.80

-0.4 (-3.57%)

07:31
09/19/17
09/19
07:31
09/19/17
07:31

Mirati Therapeutics initiated with an Outperform at Oppenheimer

Oppenheimer analyst Leah Rush Cann started Mirati Therapeutics with an Outperform rating and $18 price target as she anticipates several data releases before the end of 2017 that will inform its continued development of its three lead compounds as well as a fourth compound entering clinical development. The analyst estimates that Mirati will first have product revenue in 2022 resulting in total revenue that year of $390.2M, potentially growing to $1.64B in 2023, if all three compounds are successful in currently planned indications.

  • 25

    Sep

MRTX Mirati Therapeutics
$10.80

-0.4 (-3.57%)

11/17/16
HCWC
11/17/16
INITIATION
Target $12
HCWC
Buy
Mirati Therapeutics initiated with a Buy at H.C. Wainwright
H.C. Wainwright analyst Shaunak Deepak started Mirati Therapeutics with a Buy rating and $12 price target.
09/15/17
LEER
09/15/17
NO CHANGE
Target $9
LEER
Market Perform
Mirati reported encouraging update on sitravatinib, says Leerink
Leerink analyst Michael Schmidt says Mirati Therapeutics eported an encouraging update from its ongoing early stage clinical trials of anti-cancer agent sitravatinib. While patient numbers are still very small, these early updates are positive news and could potentially have a beneficial effect on the accrual of ongoing single agent cohort, Schmidt tells investors in a research note. The analyst raised his price target for Mirati shares to $9 from $7 to reflect a probability-adjusted value for the Opdivo combination opportunity for sitravatinib in non-squamous non-small cell lung cancer. He keeps a Market Perform rating on the shares.
09/18/17
OPCO
09/18/17
INITIATION
Target $18
OPCO
Outperform
Mirati Therapeutics initiated with an Outperform at Oppenheimer
Oppenheimer initiated Mirati Therapeutics with an Outperform and an $18 price target.
09/19/17
SBSH
09/19/17
NO CHANGE
Target $16
SBSH
Buy
Citi doubles Mirati target, says 135% rally 'not nearly enough'
Citi analyst Yigal Nochomovitz doubled his price target for Mirati Therapeutics shares to $16 from $8 saying the response of sitravatinib in non-small cell lung cancer puts the company back on the "targeted therapy map." The shares closed yesterday down 40c to $10.80. The stock "hasn't reacted nearly enough" to Friday's CBL data, Nochomovitz tells investors in a research note. A "conservative model argues for substantially more upside" than the stock's 135% move on Friday, the analyst contends. Nochomovitz now models $300M peak revenue for sitravatinib in NSCLC with inactivating CBL mutations. The analyst keeps a Buy rating on Mirati.

TODAY'S FREE FLY STORIES

M

Macy's

$26.26

0.67 (2.62%)

13:40
02/22/18
02/22
13:40
02/22/18
13:40
Options
Bullish three-way spread in Macy's ahead of earnings »

Bullish three-way spread…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 18

    Mar

QCOM

Qualcomm

$63.40

-0.59 (-0.92%)

, AVGO

Broadcom

$248.62

-1 (-0.40%)

13:36
02/22/18
02/22
13:36
02/22/18
13:36
Hot Stocks
Qualcomm announces letter sent to stockholders, video posted to site »

Qualcomm (QCOM) announced…

QCOM

Qualcomm

$63.40

-0.59 (-0.92%)

AVGO

Broadcom

$248.62

-1 (-0.40%)

NXPI

NXP Semiconductors

$125.60

0.04 (0.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 06

    Mar

  • 22

    Mar

  • 23

    Mar

  • 27

    Mar

  • 28

    Mar

AUDVF

Audi AG

, VLKAY

Volkswagen

$40.43

-0.57 (-1.39%)

13:35
02/22/18
02/22
13:35
02/22/18
13:35
Periodicals
German prosecutors raid homes of former Audi board members, AFP says »

German prosecutors said…

AUDVF

Audi AG

VLKAY

Volkswagen

$40.43

-0.57 (-1.39%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ABX

Barrick Gold

$12.57

-0.0933 (-0.74%)

13:25
02/22/18
02/22
13:25
02/22/18
13:25
Conference/Events
Barrick Gold to host investor day »

Investor meeting to be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 25

    Feb

13:25
02/22/18
02/22
13:25
02/22/18
13:25
Conference/Events
Morgan Stanley insurance analysts to hold an analyst/industry conference call »

Analysts host Charles…

13:20
02/22/18
02/22
13:20
02/22/18
13:20
General news
Treasury's $29 B 7-year sale was a disappointment »

Treasury's $29 B…

CSGP

CoStar Group

$352.11

0.27 (0.08%)

13:18
02/22/18
02/22
13:18
02/22/18
13:18
Recommendations
CoStar Group analyst commentary  »

Stephens would be buyers…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 26

    Feb

  • 23

    May

$NSD

NASDAQ Market Internals

13:17
02/22/18
02/22
13:17
02/22/18
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

13:16
02/22/18
02/22
13:16
02/22/18
13:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:15
02/22/18
02/22
13:15
02/22/18
13:15
General news
Treasury Action: yields kicked up from lows »

Treasury Action: yields…

ALKS

Alkermes

$63.19

-1.56 (-2.41%)

, NKTR

Nektar

$86.45

3 (3.60%)

13:11
02/22/18
02/22
13:11
02/22/18
13:11
Hot Stocks
Analyst cuts Alkermes rating as cancer drug seems less effective than competitor »

Shares of Alkermes (ALKS)…

ALKS

Alkermes

$63.19

-1.56 (-2.41%)

NKTR

Nektar

$86.45

3 (3.60%)

BMY

Bristol-Myers

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 26

    Feb

  • 05

    Mar

  • 08

    Mar

  • 04

    Apr

  • 03

    May

CIDM

Cinedigm

$1.25

0.0201 (1.63%)

13:10
02/22/18
02/22
13:10
02/22/18
13:10
Hot Stocks
Cinedigm acquires North American rights to 'Class Rank' »

Cinedigm Corp has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Mar

FB

Facebook

$177.91

1.9 (1.08%)

13:09
02/22/18
02/22
13:09
02/22/18
13:09
Technical Analysis
Technical Take: Facebook trades near session lows »

The stock was last at…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 26

    Feb

  • 28

    Feb

  • 07

    Mar

  • 18

    Mar

HPQ

HP Inc.

$21.52

0.345 (1.63%)

, LNVGY

Lenovo

$10.15

-0.01 (-0.10%)

13:09
02/22/18
02/22
13:09
02/22/18
13:09
Earnings
On The Fly: What to watch for in HP Inc.'s earnings report »

HP Inc. (HPQ) is…

HPQ

HP Inc.

$21.52

0.345 (1.63%)

LNVGY

Lenovo

$10.15

-0.01 (-0.10%)

AAPL

Apple

$171.07

-0.78 (-0.45%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 23

    Feb

  • 26

    Feb

  • 24

    Apr

  • 30

    May

MIC

Macquarie Infrastructure

$39.09

-24.53 (-38.56%)

13:09
02/22/18
02/22
13:09
02/22/18
13:09
Recommendations
Macquarie Infrastructure analyst commentary  »

Macquarie Infrastructure…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

BAMXY

BMW Group

13:05
02/22/18
02/22
13:05
02/22/18
13:05
Hot Stocks
BMW to pay $2.2M to settle DOJ claims of SCRA violations »

The Justice Department…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:05
02/22/18
02/22
13:05
02/22/18
13:05
General news
7-Yr Note Auction Coupon Rate data reported »

7-Yr Note Auction Coupon…

13:05
02/22/18
02/22
13:05
02/22/18
13:05
General news
7-Yr Note Auction Total Amount data reported »

7-Yr Note Auction Total…

W

Wayfair

$74.55

-21.14 (-22.09%)

13:05
02/22/18
02/22
13:05
02/22/18
13:05
Recommendations
Wayfair analyst commentary  »

Citi trims Wayfair target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

EAT

Brinker

13:05
02/22/18
02/22
13:05
02/22/18
13:05
Options
Brinker call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VIAB

Viacom

$33.03

-0.95 (-2.80%)

, VIA

Viacom

$38.35

-1.15 (-2.91%)

13:04
02/22/18
02/22
13:04
02/22/18
13:04
Hot Stocks
SEGA, Paramount announce agreement to co-produce Sonic the Hedgehog feature film »

SEGA Holdings announced…

VIAB

Viacom

$33.03

-0.95 (-2.80%)

VIA

Viacom

$38.35

-1.15 (-2.91%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 26

    Feb

GOOGL

Alphabet Class A

$1,113.75

10.16 (0.92%)

12:55
02/22/18
02/22
12:55
02/22/18
12:55
Technical Analysis
Technical Take: Alphabet Class A moves lower in intraday rounding pattern »

The shares have dropped…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

DPS

Dr Pepper Snapple

$115.28

-0.1 (-0.09%)

12:55
02/22/18
02/22
12:55
02/22/18
12:55
Options
Dr Pepper Snapple put volume heavy and directionally bearish »

Bearish flow noted in Dr…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:55
02/22/18
02/22
12:55
02/22/18
12:55
General news
Treasury Option Action: a rash of put buying »

Treasury Option Action: a…

12:55
02/22/18
02/22
12:55
02/22/18
12:55
Conference/Events
CFA Society of Milwaukee to hold a luncheon discussion »

Bill Stone, CMT of PNC…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.